低容量医院行胸主动脉腔内修复术后结局并非更差
基于血管质量倡议数据库2015年1月至2019年12月行胸主动脉腔内修复术的3584例患者(1720例无症状、1864例有症状或破裂),在147个中心比较低容量与高容量医院结局。低容量医院年均TEVAR中位数6例、高容量17例。校正后低容量医院30天死亡率和主要并发症风险均未增加。
要点
- 低容量医院年均TEVAR中位数6例,高容量医院17例。
- 无症状患者30天死亡率低容量医院3.7% vs 高容量医院3.7%(P=.98)。
- 有症状或破裂患者30天死亡率低容量医院9.3% vs 高容量医院7.3%(P=.13)。
核心结论
- 利用大型全国数据库显示,低容量医院行TEVAR的结局与高容量医院相比并非更差。
- 作者认为手术技术层面可能解释不同机构经验下结局的相似性。
研究设计与样本
- 从血管质量倡议数据库识别2015年1月至2019年12月行TEVAR的患者。
- 参与中心按容量分为低容量医院和高容量医院。
- 采用多变量logistic回归分析评估医院容量对30天死亡率和主要术后并发症的影响。
- 共纳入147个中心的3584例TEVAR患者,其中1720例无症状、1864例有症状或破裂。
主要发现
- 低容量医院和高容量医院年均TEVAR中位数分别为6例和17例。
- 30天死亡率无症状患者低容量医院3.7% vs 高容量医院3.7%(P=.98),有症状或破裂患者低容量医院9.3% vs 高容量医院7.3%(P=.13),均无显著差异。
- 校正多个临床和解剖因素后,低容量医院治疗与30天死亡率增加无关(无症状:比值比0.98,95%CI 0.52-1.87,P=.96;有症状或破裂:比值比1.15,95%CI 0.75-1.77,P=.53)。
- 低容量医院治疗与主要并发症风险增加无关,包括肾脏、神经、心脏、肺和股动脉入路并发症(所有P>.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracic endovascular aortic repair (TEVAR) has been increasingly used to treat complex thoracic aortic pathology. In the present study, we assessed the hospital volume's effects on the outcomes of patients who had undergone TEVAR. METHODS: Patients who had undergone TEVAR from January 2015 to December 2019 were identified from the Vascular Quality Initiative database. The participating centers were stratified by volume as low-volume hospitals (LVHs) and high-volume hospitals (HVHs). We assessed the effects of hospital volume on 30-day mortality and major postoperative complications using multivariable logistic regression analysis. RESULTS: A total of 3584 TEVAR patients (1720 asymptomatic and 1864 symptomatic or ruptured) were identified at 147 centers. The median average annual number of TEVAR cases at the LVHs and HVHs was 6 and 17 cases, respectively. No significant differences were found in 30-day mortality between the LVHs and HVHs (asymptomatic, 3.7% vs 3.7% [P = .98]; symptomatic or ruptured, 9.3% vs 7.3% [P = .13]). After adjusting for multiple clinical and anatomic factors, treatment at a LVH was not associated with increased 30-day mortality (asymptomatic: odds ratio, 0.98; 95% confidence interval, 0.52-1.87; P = .96; symptomatic or ruptured: odds ratio, 1.15; 95% confidence interval, 0.75-1.77; P = .53) nor an increased risk of major complications, including renal, neurologic, cardiac, pulmonary, and femoral artery access complications (P > .05 for all). CONCLUSIONS: Using a large national database, we have demonstrated that treatment at LVHs is not associated with inferior TEVAR outcomes compared with HVHs. The technical aspect of the procedure might play a role in the similarity of outcomes across the different institutional experiences.
引用
- Alhajri N, Yin K, Locham S, et al. Low-volume hospitals are not associated with inferior outcomes after thoracic endovascular aortic repair. J Vasc Surg. 2021. PMID: 34848350. doi:10.1016/j.jvs.2021.11.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。